RevMed Catalog

RevMed Content

https://admin.revmedconnect.com/api/asset/content/revmed-logo-1.jpg?contextRequest=%7B%22forceCatalogForFetch%22:false,%22tenantId%22:%225DF1363059675161A85F576D%22%7D

RevMed

https://admin.revmedconnect.com/api/asset/content/RevMed-Graphic-Navy-large.png?contextRequest=%7B%22forceCatalogForFetch%22:false,%22tenantId%22:%225DF1363059675161A85F576D%22%7D

RevMed Tenant

The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).

Lixelle 

specialty

fdaProductCodeNames

brand

prices

inStockQuantity

expirationDate

visibleListings

vendorRef

listingDates

deviceSterile

sterilizationPriorToUse

singleUse

name

price

catalogNumber

companyName

availabilityCount

availabilityMinPrice

KANEKA CORPORATION
CATALOG #	QTY	PRICE	DESCRIPTION
N/A	0	-	The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
N/A	0	-	The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).
N/A	0	-	The Lixelle(r) beta 2-microglobulin apheresis column is indicated for the treatment of patients with clinically-diagnosed dialysis-related amyloidosis (DRA).

Beta 2-Microglobulin Apheresis Column

Beta 2-Microglobulin Apheresis Column